Buscopan
Buscopan is a medicine authorised by Swissmedic under authorisation number 17354. The authorisation holder is Opella Healthcare Switzerland AG. The medicinal product code is Synthetic medicines and the dispensing category is D: Supplied in pharmacies and drugstores after specialist advice, without a prescription. First authorisation was granted on 14 June 1952 and the authorisation is valid without a time limit. ATC code A03BB01 places the medicine in the group Drugs for functional gastrointestinal disorders.
| Authorisation number | 17354 |
|---|---|
| Name | Buscopan |
| Full name | Buscopan, Suppositorien |
| Authorisation holder | Opella Healthcare Switzerland AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | D · No prescription, with advice |
| ATC code | A03BB01 |
| First authorisation | 14 June 1952 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Buscopan, Suppositorien | D | 14 June 1952 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 19 | 6 | Suppositorien | A03BB01 | 04.02.0. | D |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Buscopan authorised in Switzerland?
Yes. Buscopan is authorised by Swissmedic under authorisation number 17354, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Buscopan have?
Buscopan is in dispensing category D. Supplied in pharmacies and drugstores after specialist advice, without a prescription.
Who is the authorisation holder of Buscopan?
The authorisation holder is Opella Healthcare Switzerland AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.